Media release
From:
JAMA
About The Study: In this study of 142,000 live births in Ontario, Canada, maternal mRNA COVID-19 vaccination during pregnancy was associated with lower risks of severe neonatal morbidity, neonatal death, and neonatal intensive care unit admission and no increase in neonatal readmission or hospital admission up to age six months, compared with no maternal COVID-19 vaccination before delivery.
Authors: Jeffrey C. Kwong, M.D., M.Sc., of ICES in Toronto, is the corresponding author.
Attachments
Note: Not all attachments are visible to the general public.
Research URLs will go live after the embargo ends.
Research
JAMA, Web page
The URL will go live after the embargo ends
Journal/
conference:
JAMA Pediatrics
Organisation/s:
University of Toronto, Canada
Funder:
This study was supported by
ICES, which is funded by an annual grant from the
Ontario Ministry of Health and the Ministry of
Long-Term Care. This study also received funding
from: the Canadian Immunization Research
Network through a grant from the Public Health
Agency of Canada and the Canadian Institutes of
Health Research (CNF 151944), the Public Health
Agency of Canada, through the Vaccine
SurveillanceWorking Party, and the COVID-19
Immunity Task Force and the Ontario Health Data
Platform, a Province of Ontario initiative to support
Ontario’s ongoing response to COVID-19 and its
related impacts. Dr Kwong is supported by a
Clinician-Scientist Award from the University of
Toronto Department of Family and Community
Medicine. Dr Gutmann was supported by Canada
Research Chairs. Dr Jorgensen is supported by a
trainee grant from the Canadian Immunization
Research Network.
Sign In
International
